The invention provides novel LRP5-binding polypeptides, and more specificallynovel LRP5-binding immunoglobulinsingle variable domain constructs which can inhibit Wnt signaling pathways.The invention also relates to specific sequences of suchpolypeptides, methods of their production, and methods of using them,including methods of treatment of diseases such as cancer.